Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 07, 2026
TickeronGET DAILY SIGNALS
Emerson (EMR) vs Rockwell (ROK): Weighing Momentum in Industrial Automation

Emerson (EMR) vs Rockwell (ROK): Weighing Momentum in Industrial Automation

Key Takeaways

  • EMR is showing stronger momentum, backed by double-digit order growth and a raised outlook, while ROK faces pressure from slowing recurring-revenue growth.
  • Tickeron AI Verdict: EMR — Emerson's more consistent trend, broader end-market diversification, and accelerating demand profile give it the edge.
  • Both are leading industrial automation names, but EMR is a diversified global automation and software leader, while ROK is more concentrated in factory automation and discrete manufacturing.
  • ROK has delivered sharper margin expansion, yet its shares fell sharply after recent earnings on concerns about decelerating annual recurring revenue (ARR).
  • For deeper coverage, visit the EMR Major News and EMR Today's Price Move pages, as well as the ROK Major News and ROK Today's Price Move pages.
  • To see how AI-driven strategies are navigating names like these, explore the Trending AI Robots page.

Introduction

Emerson Electric Co. (EMR) and Rockwell Automation, Inc. (ROK) rank among the most closely watched industrial automation stocks. Both sit at the intersection of electrification, reshoring, and AI-enabled manufacturing. Their business models and recent results, however, have taken different paths, and the latest quarterly reports sent their shares in opposite directions. This comparison helps clarify how their positioning and momentum differ within the sector.

Emerson's Recent Momentum

Emerson Electric, based in St. Louis, Missouri, operates as a diversified global automation and technology company across industrial, commercial, and residential markets. It has shifted its portfolio toward higher-margin automation and software, with the AspenTech integration now complete ahead of schedule. The company reports across Software & Systems, Intelligent Devices, and Safety & Productivity groups.

Recent results showed resilient demand. Underlying orders rose by a double-digit percentage in the latest quarter, supported by long-cycle projects in power generation, LNG, semiconductors, and aerospace & defense. Management raised its full-year outlook for sales, earnings, and free cash flow, while noting ongoing softness in Europe and China. The stock's performance has reflected this broad-based strength and more consistent top-line growth alongside expanding segment margins. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Rockwell's Performance and Challenges

Rockwell Automation, headquartered in Milwaukee, Wisconsin, specializes in industrial automation and digital transformation, with a focus on factory automation controls, drives, software, and connected services. Its exposure leans more toward discrete manufacturing and process industries such as automotive, food and beverage, mining, and energy.

The company posted strong profitability gains, with enterprise operating margin hitting its long-term target ahead of schedule and adjusted EPS rising sharply year over year. The Software & Control segment grew solidly, led by the Logix platform. Yet organic ARR growth slowed, and revenue missed consensus partly due to tariff-related refund accounting. Shares declined sharply after the report, as investors focused on the trajectory of recurring revenue rather than the earnings beat.

Head-to-Head Comparison

Although both companies operate in industrial automation, their profiles differ. EMR is larger and more diversified, with a substantial software component, wider geographic reach, and significant exposure to energy, power, and process markets. ROK remains more concentrated on discrete factory automation and shorter-cycle demand tied to manufacturing activity.

Growth drivers also vary. EMR has benefited from investment in electrification, energy security, and reshoring, which produced accelerating orders and an expanding project funnel. ROK has seen gains from new products and share growth in its Logix platform, along with traction in semiconductors and data centers, but its recurring-revenue growth has decelerated.

Risk factors diverge as well. EMR contends with softness in Europe and China and greater exposure to cyclical energy and process projects. ROK faces sensitivity to manufacturing capital spending, component-cost inflation, and the market's reaction to slowing ARR growth despite strong margins. Sentiment has generally favored EMR for its broadening demand, while ROK drew a more cautious response.

Tickeron AI Verdict

Based on trend consistency, breadth of demand, and relative positioning, Tickeron's AI currently favors EMR over ROK. Emerson's accelerating order growth, rising project funnel, diversified end-market mix, and raised outlook point to more stable momentum. Rockwell's margin gains are offset by decelerating recurring-revenue growth and a share-price reaction that reflects investor concern about sustainability. This view is probabilistic and reflects the current balance of fundamentals rather than a guarantee of future results.

Using AI Tools for Market Perspective

When evaluating names like these, I sometimes review Tickeron’s Trending AI Robots to observe how automated strategies are positioned across the market. The section highlights bots with the strongest alignment to current conditions, offering a data-driven view of trading approaches without replacing individual analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: EMR, ROK

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Momentum Indicator for EMR turns positive, indicating new upward trend

EMR saw its Momentum Indicator move above the 0 level on October 27, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In 60 of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at 66%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +2.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where EMR advanced for three days, in 219 of 345 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

The Aroon Indicator entered an Uptrend today. In 151 of 274 cases where EMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.

Bearish Trend Analysis

The 10-day RSI Indicator for EMR moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 19 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 45%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 34 of 60 cases where EMR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 57%.

The Moving Average Convergence Divergence Histogram (MACD) for EMR turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 27 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 61%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.

EMR broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 18 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. EMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 36 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.444) is normal, around the industry mean (3.761). P/E Ratio (35.370) is within average values for comparable stocks, (36.274). Projected Growth (PEG Ratio) (1.837) is also within normal values, averaging (1.879). Dividend Yield (0.014) settles around the average of (0.032) among similar stocks. P/S Ratio (4.409) is also within normal values, averaging (186.943).

Notable companies

The most notable companies in this group are Illinois Tool Works (NYSE:ITW), Ingersoll Rand (NYSE:IR), Generac Holdings (NYSE:GNRC).

Industry description

The industry makes and maintains machines for consumers, the industry, and most other companies. While it has traditionally been categorized as heavy industry, some smaller companies are also branching into the light category. The industry is pivotal in providing the equipment for production in businesses like agriculture, mining, industry and construction, gas, electricity and water utilities. It also supplies supporting equipment for almost all sectors of the economy, such as equipment for heating, and air conditioning of buildings. Illinois Tool Works Inc., Parker-Hannifin Corporation and Rockwell Automation Inc are some of the major U.S. companies operating in this industry.

Market Cap

The average market capitalization across the Industrial Machinery Industry is 14.15B. The market cap for tickers in the group ranges from 3.71K to 242.5B. SIEGY holds the highest valuation in this group at 242.5B. The lowest valued company is SPEC at 3.71K.

High and low price notable news

The average weekly price growth across all stocks in the Industrial Machinery Industry was -3%. For the same Industry, the average monthly price growth was -16%, and the average quarterly price growth was -22%. SPPL experienced the highest price growth at 29%, while GCDT experienced the biggest fall at -32%.

Volume

The average weekly volume growth across all stocks in the Industrial Machinery Industry was -76%. For the same stocks of the Industry, the average monthly volume growth was 14% and the average quarterly volume growth was 17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 50
Price Growth Rating: 66
SMR Rating: 70
Profit Risk Rating: 74
Seasonality Score: -3 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of process controls systems, valves and analytical instruments

Industry IndustrialMachinery

Industry
Electrical Products
Address
8027 Forsyth Boulevard
Phone
+1 314 553-2000
Employees
71000
Web
https://www.emerson.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of $1.54 billion, reflecting approximately 74% year-over-year growth. Consensus earnings per share (EPS) forecast stands at $0.28, up over 115% from the prior year.
Analysts expect Q1 2026 revenue of $3.00 billion, up 8% from $2.77 billion in the year-ago quarter. Consensus earnings per share (EPS) estimate stands at $4.31, reflecting steady profitability from the cystic fibrosis (CF) portfolio.
Emerson (EMR) vs Rockwell (ROK): Weighing Momentum in Industrial Automation